1. Real-world treatment results for ruptured blood-blister aneurysm of the internal carotid artery: analysis of a Japanese nationwide multicenter study
- Author
-
Toru Iwama, Yusuke Egashira, Yuichiro Kikkawa, Yukiko Enomoto, Miki Fujimura, Noriyuki Nakayama, Takatoshi Sorimachi, Masanori Aihara, and Takayuki Mizunari
- Subjects
medicine.medical_specialty ,Aneurysm, Ruptured ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Japan ,Modified Rankin Scale ,medicine.artery ,medicine ,Humans ,Retrospective Studies ,business.industry ,Mortality rate ,Intracranial Aneurysm ,General Medicine ,medicine.disease ,Surgery ,Treatment Outcome ,Multicenter study ,Blood blister ,Radiological weapon ,Neurology (clinical) ,Neurosurgery ,Internal carotid artery ,business ,Carotid Artery, Internal ,030217 neurology & neurosurgery - Abstract
Objective. Ruptured blood-blister aneurysm (BBA) of the internal carotid artery (ICA) remains a challenging lesion, even in the age of modern neurosurgery and endovascular treatment. This retrospective multicenter study aimed to investigate the real-world treatment choice and treatment results.Methods. We included 182 ruptured BBAs of the ICA treated at 51 neurosurgical centers in Japan between 2013 and 2017. The baseline patient characteristics, radiological features of the aneurysm, treatment modality, details of treatment, complications of treatment, treatment results were retrospectively collected. The treatment strategy was divided into deconstructive and reconstructive procedures. Primary clinical outcomes were evaluated using the modified Rankin Scale (mRS) at final follow-up.Results. Direct surgery was performed in 144 (79%) cases, and the remaining 38 (21%) cases received endovascular treatment. The majority of treatment selections were deconstructive and reconstructive procedures in the direct surgery group and endovascular treatment group, respectively. Overall, favorable clinical outcomes (mRS 0 to 2) were achieved in 66% of cases, and the mortality rate was 15% at the final follow-up (mean 23 months). There was no significant difference in clinical outcome between direct and endovascular treatment groups. Conclusion. Our large nationwide study compared the real-world treatment options for ruptured BBAs and their results. Our findings may offer beneficial information for treatment decision and for future studies investigating ruptured BBAs.
- Published
- 2021